Condition: Acute Ischemic Stroke (AIS) · Sponsor: Penumbra Inc.
The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)
This description comes directly from the study's public registry record.
Celina Wang · +49 175 1938 209 · cwang1@penumbrainc.com
Egon Wülfert · +32 470 032 028 · ewuelfert@penumbrainc.com
Always discuss trial participation with your own doctor first.
| Sir Charles Gairdner Hospital | Nedlands, Western Australia, Australia | Recruiting |
| CHU de Bordeaux - Hôpital Pellegrin | Bordeaux, France | Recruiting |
| CHU de Brest - Hôpital de la Cavale Blanche | Brest, France | Recruiting |
| Hôpital Pierre-Paul Riquet | Toulouse, France | Recruiting |
| TUM Klinikum rechts der Isar | München, Bavaria, Germany | Recruiting |
| Knappschaft Kliniken Vest Recklinghausen | Recklinghausen, Westphalia, Germany | Recruiting |
| Universitätsklinikum Augsburg | Augsburg, Germany | Recruiting |
| Universitätsklinikum Schleswig-Holstein (UKSH) Lübeck | Lübeck, Germany | Recruiting |
| Universitätsspital Basel | Basel, Basel-Landschaft, Switzerland | Recruiting |
| Inselspital Universitätsklinik für Neurologie | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07107022